Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-03-04
2009-02-17
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S561000
Reexamination Certificate
active
07491716
ABSTRACT:
The present invention provides kinase inhibitors of Formula I.
REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 5721245 (1998-02-01), Davis et al.
patent: WO98/16528 (1998-04-01), None
patent: WO 00/38675 (2000-07-01), None
patent: WO01/44235 (2001-06-01), None
patent: WO01/44247 (2001-06-01), None
patent: WO 02/10158 (2002-02-01), None
patent: WO02/46183 (2002-06-01), None
patent: WO02/46197 (2002-06-01), None
Coleman Brenda L
Eli Lilly and Company
Gaylo Paul J.
Titus Robert D.
Tucker Tina M.
LandOfFree
Purine derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine derivatives as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078905